STAAR Surgical (STAA) Stock Forecast, Price Target & Predictions
STAA Stock Forecast
STAAR Surgical stock forecast is as follows: an average price target of $54.58 (represents a 75.39% upside from STAA’s last price of $31.12) and a rating consensus of 'Buy', based on 13 wall street analysts offering a 1-year stock forecast.
STAA Price Target
The average price target for STAAR Surgical (STAA) is $54.58 based on 1-year price targets from 13 Wall Street analysts in the past 3 months, with a price target range of $85.00 to $45.03. This represents a potential 75.39% upside from STAA's last price of $31.12.
STAA Analyst Ratings
According to 13 Wall Street analysts, STAAR Surgical's rating consensus is 'Buy'. The analyst rating breakdown for STAA stock is 0 'Strong Buy' (0.00%), 11 'Buy' (84.62%), 1 'Hold' (7.69%), 1 'Sell' (7.69%), and 0 'Strong Sell' (0.00%).
STAAR Surgical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 11, 2024 | Ryan Zimmerman | BTIG | $46.00 | $38.07 | 20.83% | 47.81% |
| Apr 09, 2024 | Raj Denhoy | Jefferies | $60.00 | $50.59 | 18.61% | 92.80% |
| Apr 08, 2024 | John Young | Canaccord Genuity | $46.00 | $48.68 | -5.51% | 47.81% |
| Apr 04, 2024 | Margaret Kaczor | William Blair | $45.03 | $45.54 | -1.12% | 44.70% |
| Jan 11, 2023 | Stephens Stephens | Stephens | $85.00 | $68.56 | 23.98% | 173.14% |
| Sep 23, 2022 | - | Truist Financial | $48.00 | $71.93 | -33.27% | 54.24% |
| Sep 23, 2022 | - | RBC Capital | $52.00 | $73.19 | -28.95% | 67.10% |
| Jul 19, 2022 | - | Truist Financial | $54.00 | $74.65 | -27.66% | 73.52% |
| Apr 26, 2022 | - | Canaccord Genuity | $89.00 | $59.02 | 50.80% | 185.99% |
| Mar 23, 2022 | Michael Ciarmoli | Truist Financial | $58.00 | $71.96 | -19.40% | 86.38% |
The latest STAAR Surgical stock forecast, released on Jun 11, 2024 by Ryan Zimmerman from BTIG, set a price target of $46.00, which represents a 20.83% increase from the stock price at the time of the forecast ($38.07), and a 47.81% increase from STAA last price ($31.12).
STAAR Surgical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 4 |
| Avg Price Target | - | $46.00 | $49.26 |
| Last Closing Price | $31.12 | $31.12 | $31.12 |
| Upside/Downside | -100.00% | 47.81% | 58.29% |
In the current month, the average price target of STAAR Surgical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to STAAR Surgical's last price of $31.12. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 15, 2024 | Morgan Stanley | - | Underweight | Downgrade |
| Jun 11, 2024 | Piper Sandler | Buy | Buy | Hold |
| Apr 09, 2024 | Jefferies | Buy | Buy | Hold |
| Apr 08, 2024 | Canaccord Genuity | Hold | Hold | Hold |
| Apr 04, 2024 | William Blair | Market Perform | Outperform | Upgrade |
| Apr 04, 2024 | Stifel Nicolaus | Buy | Buy | Hold |
| Mar 11, 2024 | Barclays | Underperform | Underperform | Hold |
| Sep 15, 2023 | Needham | Buy | Buy | Hold |
| Jun 07, 2023 | William Blair | - | Market Perform | Downgrade |
| Dec 28, 2022 | Oppenheimer | Outperform | Outperform | Hold |
STAAR Surgical's last stock rating was published by Morgan Stanley on Jul 15, 2024. The company Downgrade its STAA rating from "null" to "Underweight".
STAAR Surgical Financial Forecast
STAAR Surgical Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $76.27K | $80.31M | $92.31M | $73.53M | $64.04M | $76.05M | $81.10M | $63.20M | $59.00M | $58.35M | $62.37M | $50.75M | $38.88M | $47.08M | $35.19M | $35.19M | - | $39.05M | $39.66M | $32.58M | $27.09M | $20.35M |
| Avg Forecast | $92.08M | $100.30M | $113.88M | $86.76M | $80.29M | $87.35M | $95.22M | $75.34M | $75.94M | $80.37M | $92.51M | $66.23M | $64.12M | $74.95M | $80.12M | $60.53M | $59.49M | $57.90M | $52.59M | $44.26M | $44.28M | $42.99M | $35.75M | $32.94M | $38.43M | $38.57M | $39.12M | $32.34M | $108.36M | $16.28M |
| High Forecast | $94.00M | $102.39M | $116.25M | $88.56M | $81.96M | $87.74M | $97.20M | $76.91M | $77.53M | $82.04M | $94.43M | $67.60M | $65.45M | $76.51M | $81.13M | $61.30M | $60.24M | $58.63M | $53.26M | $44.82M | $44.84M | $43.54M | $36.21M | $33.35M | $38.91M | $39.06M | $39.62M | $32.75M | $130.03M | $19.54M |
| Low Forecast | $91.58M | $99.76M | $113.27M | $86.29M | $79.86M | $87.13M | $94.71M | $74.93M | $75.54M | $79.94M | $92.01M | $65.87M | $63.77M | $74.55M | $79.80M | $60.30M | $59.26M | $57.67M | $52.39M | $44.08M | $44.10M | $42.82M | $35.61M | $32.81M | $38.28M | $38.42M | $38.97M | $32.21M | $86.69M | $13.02M |
| # Analysts | 3 | 6 | 3 | 6 | 4 | 8 | 4 | 5 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 | 7 | 7 | 16 | 20 |
| Surprise % | - | - | - | - | - | - | - | - | 0.00% | 1.00% | 1.00% | 1.11% | 1.00% | 1.01% | 1.01% | 1.04% | 0.99% | 1.01% | 1.19% | 1.15% | 0.88% | 1.10% | 0.98% | 1.07% | - | 1.01% | 1.01% | 1.01% | 0.25% | 1.25% |
STAAR Surgical's average Quarter revenue forecast for Mar 24 based on 5 analysts is $75.34M, with a low forecast of $74.93M, and a high forecast of $76.91M. STAA's average Quarter revenue forecast represents a 98672.49% increase compared to the company's last Quarter revenue of $76.27K (Dec 23).
STAAR Surgical EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 6 | 3 | 6 | 4 | 8 | 4 | 5 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 | 7 | 7 | 16 | 20 |
| EBITDA | - | - | - | - | - | - | - | - | $10.40K | $9.02M | $8.60M | $3.89M | $-847.00K | $16.92M | $19.92M | $14.03M | $7.92M | $8.28M | $11.61M | $7.11M | $3.99M | $6.15M | $164.00K | $-301.00K | - | $4.29M | $6.07M | $3.36M | $1.43M | $-1.28M |
| Avg Forecast | $11.31M | $12.32M | $13.99M | $10.66M | $9.86M | $10.73M | $11.70M | $9.26M | $9.33M | $9.87M | $11.36M | $8.14M | $7.88M | $7.47M | $9.84M | $7.44M | $7.31M | $7.11M | $6.46M | $5.44M | $5.44M | $5.28M | $4.39M | $-895.93K | $4.72M | $4.74M | $4.81M | $1.70M | $2.91M | $-939.00K |
| High Forecast | $11.55M | $12.58M | $14.28M | $10.88M | $10.07M | $10.78M | $11.94M | $9.45M | $9.52M | $10.08M | $11.60M | $8.31M | $8.04M | $8.97M | $9.97M | $7.53M | $7.40M | $7.20M | $6.54M | $5.51M | $5.51M | $5.35M | $4.45M | $-716.75K | $4.78M | $4.80M | $4.87M | $2.04M | $3.49M | $-751.20K |
| Low Forecast | $11.25M | $12.26M | $13.92M | $10.60M | $9.81M | $10.71M | $11.64M | $9.21M | $9.28M | $9.82M | $11.30M | $8.09M | $7.84M | $5.98M | $9.80M | $7.41M | $7.28M | $7.09M | $6.44M | $5.42M | $5.42M | $5.26M | $4.38M | $-1.08M | $4.70M | $4.72M | $4.79M | $1.36M | $2.33M | $-1.13M |
| Surprise % | - | - | - | - | - | - | - | - | 0.00% | 0.91% | 0.76% | 0.48% | -0.11% | 2.26% | 2.02% | 1.89% | 1.08% | 1.16% | 1.80% | 1.31% | 0.73% | 1.16% | 0.04% | 0.34% | - | 0.91% | 1.26% | 1.98% | 0.49% | 1.36% |
5 analysts predict STAA's average Quarter EBITDA for Mar 24 to be $9.26M, with a high of $9.45M and a low of $9.21M. This is 88853.28% upper than STAAR Surgical's previous annual EBITDA (Dec 23) of $10.40K.
STAAR Surgical Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 6 | 3 | 6 | 4 | 8 | 4 | 5 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 | 7 | 7 | 16 | 20 |
| Net Income | - | - | - | - | - | - | - | - | $7.76K | $4.82M | $6.06M | $2.71M | $6.10M | $10.26M | $13.04M | $9.60M | $4.92M | $6.02M | $8.57M | $4.99M | $6.38M | $3.89M | $-1.17M | $-134.00K | - | $2.39M | $3.91M | $1.37M | $583.00K | $-2.20M |
| Avg Forecast | $7.57M | $11.73M | $17.55M | $6.48M | $4.14M | $9.32M | $11.90M | $82.52M | $8.91M | $8.83M | $14.24M | $75.02M | $6.71M | $5.42M | $11.60M | $68.20M | $8.48M | $8.30M | $4.06M | $53.91M | $4.07M | $4.32M | $374.33K | $-232.22K | $3.49M | $4.61M | $4.86M | $751.85K | $1.17M | $-1.65M |
| High Forecast | $7.77M | $12.04M | $18.03M | $6.66M | $4.25M | $10.30M | $12.22M | $99.03M | $14.06M | $9.07M | $14.62M | $90.02M | $6.89M | $6.50M | $11.79M | $81.84M | $8.62M | $8.44M | $4.12M | $64.70M | $4.13M | $4.39M | $380.49K | $-185.77K | $3.54M | $4.68M | $4.94M | $902.22K | $1.41M | $-1.32M |
| Low Forecast | $7.51M | $11.64M | $17.43M | $6.44M | $4.11M | $7.36M | $11.82M | $66.02M | $6.09M | $8.77M | $14.14M | $60.02M | $6.67M | $4.33M | $11.54M | $54.56M | $8.44M | $8.26M | $4.04M | $43.13M | $4.05M | $4.30M | $372.43K | $-278.66K | $3.47M | $4.58M | $4.83M | $601.48K | $939.60K | $-1.98M |
| Surprise % | - | - | - | - | - | - | - | - | 0.00% | 0.55% | 0.43% | 0.04% | 0.91% | 1.89% | 1.12% | 0.14% | 0.58% | 0.73% | 2.11% | 0.09% | 1.57% | 0.90% | -3.13% | 0.58% | - | 0.52% | 0.81% | 1.82% | 0.50% | 1.33% |
STAAR Surgical's average Quarter net income forecast for Mar 24 is $82.52M, with a range of $66.02M to $99.03M. STAA's average Quarter net income forecast represents a 1063887.24% increase compared to the company's last Quarter net income of $7.76K (Dec 23).
STAAR Surgical SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 6 | 3 | 6 | 4 | 8 | 4 | 5 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 | 7 | 7 | 16 | 20 |
| SG&A | - | - | - | - | - | - | - | - | $50.32K | $45.87M | $62.13M | $44.45M | $39.03M | $37.14M | $38.22M | $29.21M | $28.54M | $29.19M | $30.29M | $23.41M | $19.07M | $21.24M | $18.17M | $19.00M | - | $19.56M | $19.19M | $16.98M | $13.59M | $11.89M |
| Avg Forecast | $46.65M | $50.82M | $57.70M | $43.95M | $40.68M | $44.25M | $48.24M | $38.17M | $38.48M | $40.72M | $46.87M | $33.55M | $32.49M | $26.27M | $40.59M | $30.67M | $30.14M | $29.33M | $26.64M | $22.42M | $22.43M | $21.78M | $18.11M | $32.92M | $19.47M | $19.54M | $19.82M | $9.34M | $27.52M | $8.92M |
| High Forecast | $47.62M | $51.87M | $58.90M | $44.87M | $41.53M | $44.45M | $49.25M | $38.96M | $39.28M | $41.57M | $47.84M | $34.25M | $33.16M | $31.53M | $41.10M | $31.06M | $30.52M | $29.70M | $26.98M | $22.71M | $22.72M | $22.06M | $18.34M | $39.51M | $19.71M | $19.79M | $20.07M | $11.21M | $33.02M | $10.70M |
| Low Forecast | $46.40M | $50.54M | $57.39M | $43.72M | $40.46M | $44.15M | $47.98M | $37.96M | $38.27M | $40.50M | $46.62M | $33.37M | $32.31M | $21.02M | $40.43M | $30.55M | $30.02M | $29.22M | $26.54M | $22.34M | $22.34M | $21.70M | $18.04M | $26.34M | $19.39M | $19.46M | $19.74M | $7.47M | $22.02M | $7.13M |
| Surprise % | - | - | - | - | - | - | - | - | 0.00% | 1.13% | 1.33% | 1.32% | 1.20% | 1.41% | 0.94% | 0.95% | 0.95% | 1.00% | 1.14% | 1.04% | 0.85% | 0.98% | 1.00% | 0.58% | - | 1.00% | 0.97% | 1.82% | 0.49% | 1.33% |
STAAR Surgical's average Quarter SG&A projection for Mar 24 is $38.17M, based on 5 Wall Street analysts, with a range of $37.96M to $38.96M. The forecast indicates a 75753.03% rise compared to STAA last annual SG&A of $50.32K (Dec 23).
STAAR Surgical EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 3 | 6 | 3 | 6 | 4 | 8 | 4 | 5 | 6 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 5 | 11 | 15 | 8 | 8 | 10 | 14 | 7 | 7 | 16 | 20 |
| EPS | - | - | - | - | - | - | - | - | $0.16 | $0.10 | $0.13 | $0.06 | $0.13 | $0.21 | $0.27 | $0.20 | $0.10 | $0.13 | $0.18 | $0.11 | $0.14 | $0.08 | $-0.03 | $-0.00 | - | $0.05 | $0.09 | $0.03 | $0.01 | $-0.05 |
| Avg Forecast | $0.15 | $0.24 | $0.35 | $0.13 | $0.08 | $0.19 | $0.24 | $0.06 | $0.18 | $0.18 | $0.29 | $0.07 | $0.13 | $0.20 | $0.23 | $0.15 | $0.17 | $0.17 | $0.08 | $0.03 | $0.08 | $0.09 | $0.01 | $0.03 | $0.07 | $0.09 | $0.10 | $0.04 | $-0.08 | $-0.03 |
| High Forecast | $0.16 | $0.24 | $0.36 | $0.13 | $0.09 | $0.21 | $0.25 | $0.06 | $0.28 | $0.18 | $0.29 | $0.08 | $0.14 | $0.21 | $0.24 | $0.15 | $0.17 | $0.17 | $0.08 | $0.03 | $0.08 | $0.09 | $0.01 | $0.03 | $0.07 | $0.09 | $0.10 | $0.05 | $-0.06 | $-0.02 |
| Low Forecast | $0.15 | $0.23 | $0.35 | $0.13 | $0.08 | $0.15 | $0.24 | $0.06 | $0.12 | $0.18 | $0.28 | $0.07 | $0.13 | $0.20 | $0.23 | $0.15 | $0.17 | $0.17 | $0.08 | $0.03 | $0.08 | $0.09 | $0.01 | $0.03 | $0.07 | $0.09 | $0.10 | $0.04 | $-0.10 | $-0.04 |
| Surprise % | - | - | - | - | - | - | - | - | 0.89% | 0.56% | 0.45% | 0.81% | 0.96% | 1.05% | 1.16% | 1.33% | 0.59% | 0.78% | 2.21% | 3.30% | 1.71% | 0.92% | -3.99% | -0.11% | - | 0.54% | 0.92% | 0.67% | -0.13% | 1.67% |
According to 5 Wall Street analysts, STAAR Surgical's projected average Quarter EPS for Mar 24 is $0.06, with a low estimate of $0.06 and a high estimate of $0.06. This represents a -61.72% decrease compared to STAA previous annual EPS of $0.16 (Dec 23).
STAAR Surgical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $106.59 | $298.00 | 179.58% | Buy |
| ANGO | AngioDynamics | $7.17 | $17.00 | 137.10% | Buy |
| STAA | STAAR Surgical Company | $31.12 | $54.58 | 75.39% | Buy |
| HAE | Haemonetics | $73.24 | $112.00 | 52.92% | Buy |
| NVST | Envista | $17.44 | $23.83 | 36.64% | Hold |
| RGEN | Repligen | $147.07 | $189.50 | 28.85% | Buy |
| BDX | Becton, Dickinson and Company | $232.67 | $280.55 | 20.58% | Buy |
| WST | West Pharmaceutical Services | $297.24 | $345.33 | 16.18% | Buy |
| HOLX | Hologic | $81.57 | $78.92 | -3.25% | Buy |
| MMSI | Merit Medical Systems | $96.58 | $92.13 | -4.61% | Buy |
| RMD | ResMed | $244.87 | $209.33 | -14.51% | Hold |
| ICUI | ICU Medical | $162.32 | $135.00 | -16.83% | Buy |
| ATR | AptarGroup | $152.38 | $100.00 | -34.37% | Buy |
STAA Forecast FAQ
Is STAAR Surgical a good buy?
Yes, according to 13 Wall Street analysts, STAAR Surgical (STAA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 11 'Buy' recommendations, accounting for 84.62% of STAA's total ratings.
What is STAA's price target?
STAAR Surgical (STAA) average price target is $54.58 with a range of $45.03 to $85, implying a 75.39% from its last price of $31.12. The data is based on 13 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will STAAR Surgical stock go up soon?
According to Wall Street analysts' prediction for STAA stock, the company can go up by 75.39% (from the last price of $31.12 to the average price target of $54.58), up by 173.14% based on the highest stock price target, and up by 44.70% based on the lowest stock price target.
Can STAAR Surgical stock reach $50?
STAA's average twelve months analyst stock price target of $54.58 supports the claim that STAAR Surgical can reach $50 in the near future.
What are STAAR Surgical's analysts' financial forecasts?
STAAR Surgical's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $338.19M (high $343.81M, low $336.63M), average EBITDA is $41.55M (high $42.24M, low $41.36M), average net income is $107.88M (high $125.8M, low $89.3M), average SG&A $171.35M (high $174.19M, low $170.55M), and average EPS is $0.57 (high $0.6, low $0.528). STAA's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $393.01M (high $401.2M, low $390.9M), average EBITDA is $48.28M (high $49.29M, low $48.02M), average net income is $43.32M (high $44.49M, low $43.02M), average SG&A $199.12M (high $203.27M, low $198.05M), and average EPS is $0.87 (high $0.893, low $0.864).
Did the STAA's actual financial results beat the analysts' financial forecasts?
Based on STAAR Surgical's last annual report (Dec 2023), the company's revenue was $322.42K, which missed the average analysts forecast of $315.05M by -99.90%. Apple's EBITDA was $28.1K, missing the average prediction of $38.71M by -99.93%. The company's net income was $21.35K, missing the average estimation of $107M by -99.98%. Apple's SG&A was $224.55K, missing the average forecast of $159.62M by -99.86%. Lastly, the company's EPS was $0.43, missing the average prediction of $0.716 by -39.92%. In terms of the last quarterly report (Dec 2023), STAAR Surgical's revenue was $76.27K, missing the average analysts' forecast of $75.94M by -99.90%. The company's EBITDA was $10.4K, missing the average prediction of $9.33M by -99.89%. STAAR Surgical's net income was $7.76K, missing the average estimation of $8.91M by -99.91%. The company's SG&A was $50.32K, missing the average forecast of $38.48M by -99.87%. Lastly, the company's EPS was $0.16, missing the average prediction of $0.179 by -10.51%